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Abstract
In budding yeast, asymmetric cell division yields a larger mother and a smaller daughter cell, which transcribe different
genes due to the daughter-specific transcription factors Ace2 and Ash1. Cell size control at the Start checkpoint has long
been considered to be a main regulator of the length of the G1 phase of the cell cycle, resulting in longer G1 in the smaller
daughter cells. Our recent data confirmed this concept using quantitative time-lapse microscopy. However, it has been
proposed that daughter-specific, Ace2-dependent repression of expression of the G1 cyclin CLN3 had a dominant role in
delaying daughters in G1. We wanted to reconcile these two divergent perspectives on the origin of long daughter G1
times. We quantified size control using single-cell time-lapse imaging of fluorescently labeled budding yeast, in the
presence or absence of the daughter-specific transcriptional regulators Ace2 and Ash1. Ace2 and Ash1 are not required for
efficient size control, but they shift the domain of efficient size control to larger cell size, thus increasing cell size
requirement for Start in daughters. Microarray and chromatin immunoprecipitation experiments show that Ace2 and Ash1
are direct transcriptional regulators of the G1 cyclin gene CLN3. Quantification of cell size control in cells expressing titrated
levels of Cln3 from ectopic promoters, and from cells with mutated Ace2 and Ash1 sites in the CLN3 promoter, showed that
regulation of CLN3 expression by Ace2 and Ash1 can account for the differential regulation of Start in response to cell size in
mothers and daughters. We show how daughter-specific transcriptional programs can interact with intrinsic cell size control
to differentially regulate Start in mother and daughter cells. This work demonstrates mechanistically how asymmetric
localization of cell fate determinants results in cell-type-specific regulation of the cell cycle.
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Introduction
At the Start transition in G1, budding yeast cells integrate
internal and external cues into an all-or-none commitment to a
new round of cell division [1,2]. Cell division is asymmetric,
producing a smaller daughter cell and a larger mother cell [3].
Mother cells progress through Start more quickly than daughter
cells [3,4]. The regulation of G1 phase is composed of two
independent modules separated by the nuclear exit of the
transcriptional repressor Whi5 [5]: a cell size sensing module,
which extends G1 in small cells to allow additional growth before
Start [5], and a subsequent size-independent module [5,6]. The
fast and coherent transition between the two modules likely
coincides with commitment to the cell cycle and is driven by
transcriptional positive feedback [7]. The G1 cyclin Cln3 is the
most upstream activator of the Start transition [8,9,10,11,12] and
the main regulator of the size-sensing module. Cln3 initiates
inactivation of Whi5 [13,14] and expression of SBF/MBF
dependent genes, including the G1 cyclins CLN1 and CLN2
[9,11,12,15,16]. Subsequent positive feedback of Cln1 and Cln2
on SBF/MBF dependent transcription ensures fast and coherent
commitment to the cell cycle [7].
Cell size control is thought to regulate the length of the G1
phase of the cell cycle [4,5,17,18]. In budding yeast, cell size
control is readily detectable in daughter cells but much less
obvious in mother cells. In part this is because mother cells are
almost always born larger than daughters [3], but it has also been
shown that daughters are slower to pass Start than mothers even
when both are made equally large (greater than normal mother or
daughter size) [19]. This finding suggested some asymmetry in
Start control between mothers and daughters beyond that due to
different cell size; differential gene expression in mothers and
daughters could provide such asymmetry.
Regulation of gene expression is asymmetric in mother and
daughter cells as a result of the daughter-specific localization of the
transcription factors Ace2 and Ash1. Ace2 enters mother and
daughter nuclei during mitotic exit [20,21]. Asymmetric localiza-
tion of Ace2 is due to the Mob2-Cbk1 complex [20,21,22], which
promotes nuclear retention of Ace2 specifically in the newborn
daughter nucleus, leading to daughter-specific expression of a
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of Ash1 is achieved through active transport of ASH1 mRNA to
the bud tip and consequent preferential accumulation of Ash1 in
the daughter nucleus [25]. Ash1 represses expression of the HO
endonuclease gene responsible for mating type switching [26,27],
thus restricting HO expression to mother cells.
Recently, Ace2 was shown to cause a daughter-specific G1 delay,
acting indirectly through ‘‘Daughter Delay Elements (DDE)’’ 59 to
the CLN3 coding sequence to reduce CLN3 expression in daughters
[28]. In that work, it was proposed that this Ace2-dependent delay is
the only reason that daughters have a longer G1 than mothers. Cell
sizewasproposed to playno roleincontrolling thelength ofG1[28].
This proposal is incompatible with our recent finding that small cells
display very efficient size control, requiring a significantly longer
period of growth to attain a sufficient size before exiting G1 [5].
Here, we resolve this conflict and further investigate the differences
between mother and daughter cell cycle control by analyzing the
interaction between daughter-specific transcriptional programs, cell
size control, and irreversible commitment to the cell cycle at Start.
Results
Differential Regulation of Start in Mothers and Daughters
Is Dependent on Ace2 and Ash1
G1 (defined operationally as the unbudded period of the cell
cycle) can be decomposed into two independent steps, of duration
T1 and T2, respectively, separated by exit from the nucleus of the
transcriptional repressor Whi5 (Figure 1A) [5]. We previously used
time-lapse fluorescence microscopy of yeast expressing WHI5-GFP
and ACT1pr-DsRed [5] to simultaneously measure the duration of
T1, measured by the interval of Whi5 nuclear residence, and cell
size, measured using total cell fluorescence expressed from the
constitutive ACT1pr-DsRed [5]. T2, the time between Whi5 nuclear
exit and budding, is similar in mothers and daughters and is
largely independent of cell size [5,6]. T1 is extremely short in
mothers but of significant duration in daughters [5,6]. G1 size
control is readily detected in small daughter cells, and maps
specifically to the T1 interval [5].
Smaller cells have a longer T1, allowing growth to a larger size
before cell cycle entry. This links birth size to T1 duration. Given
exponential growth of single cells [5,29],the size at Whi5 exit, M1,i s
related to the size at birth, Mbirth, through the period T1 by the
simple formula: M1=Mbirthe
aT1, where a is the growth rate for
exponential growth. This expression yields: aT1=ln(M1)–ln(Mbirth).
The correlation between aT1 and ln(Mbirth) characterizes the
efficiency of size control. If there is efficient size control, then T1
should become larger as ln(Mbirth) becomes smaller, because cells
born smaller require a longer period of growth to promote Start.
Specifically, the slope of the linear fit of the plot of aT1 against
ln(Mbirth) should be 21 in the case of perfect size control (that is, an
exact size at which Start is invariably executed) and 0 in the absence
of size control [5,30].
The different duration of the period T1 in mothers and
daughters could in principle be solely a consequence of size control
imposing a delay in the smaller daughter cells [3]. We analyzed the
correlation between aT1 and ln(Mbirth), comparing mothers and
daughters binned for very similar size at birth (binning was
necessary to ensure sufficient numbers of cells of a given size for
statistical comparisons). This comparison demonstrates an increase
in aT1 in daughters compared to mothers of similar size
(Figure 1B, 1C; regions marked with bars) (p values,10
26; Table
S4). This delay in Start is most readily detectable in glycerol-
ethanol medium (Figure 1C) (p value,10
270; Table S4), in which
cell growth is much slower than in glucose medium. Slower growth
means that the mother cell feeds less biomass into the daughter
cell, resulting in smaller daughter size at the time of cell division
[3]. The resulting population of very small daughters enhances
detection of size control (Figure 1C) [5]. In glycerol-ethanol, across
the domain of size overlap in mother-daughter size at birth,
daughters exhibit clear size control (slope ,20.8) while mothers
exhibit essentially none (slope ,0). This increase in aT1 in
daughters with respect to mothers of equal size is consistent with
previous findings of a daughter-specific delay, above and beyond
the delay needed to achieve equivalent size [19,28].
Laabs and collaborators had previously implicated the daugh-
ter-specific transcription factor Ace2 in delayed exit from G1 in
daughters [28]. Ash1 is a second daughter-specific transcription
factor [26,27], and Ace2 contributes to the expression of ASH1 in
daughter cells [31]. Ash1 might therefore be the effector of the
Ace2-induced daughter delay, or it could independently contribute
to daughter delay. We analyzed the correlation between aT1 and
ln(Mbirth)i nace2 and ash1 single and double mutants (for a
complete list of strains and plasmids used in this study, see Table
S1 and Table S2).
ace2 ash1 mothers and daughters that were born at similar sizes
exhibited similar aT1 values, failing to display the daughter-
specific delay seen in wild-type (Figure 1H, 1I, and Table 1).
Furthermore, only very small ace2 ash1 daughters from glycerol/
ethanol cultures displayed efficient size control. It is important to
note that the mutant still displayed efficient size control by our
metric; the effect of the deletions was to shift the size domain
where efficient size control could be detected, not to eliminate size
control per se.
Single mutants (ace2 ASH1 and ACE2 ash1) display a phenotype
similar to but less extreme than ace2 ash1 double mutants
(Figure 1D–1G, Table 1). Ace2 contributes to transcriptional
activation of ASH1 [31], so some but not all of the effects of ACE2
deletion may be a consequence of reduced ASH1 expression. The
characterized indirect effect of Ace2 on DDE sites 59 of CLN3
coding sequence [28] likely accounts for at least some of the Ash1-
independent effect of ACE2 deletion; we argue below that there is
likely an additional direct effect of Ace2 on CLN3 transcription.
Author Summary
Asymmetric cell division is a universal mechanism for
generating differentiated cells. The progeny of such
divisions can often display differential cell cycle regulation.
This study addresses how differential regulation of gene
expression in the progeny of a single division can alter cell
cycle control. In budding yeast, asymmetric cell division
yields a bigger ‘mother’ cell and a smaller ‘daughter’ cell.
Regulation of gene expression is also asymmetric because
two transcription factors, Ace2 and Ash1, are specifically
localized to the daughter. Cell size has long been
proposed as important for the regulation of the cell cycle
in yeast. Our work shows that Ace2 and Ash1 regulate size
control in daughter cells: daughters ‘interpret’ their size as
smaller, making size control more stringent and delaying
cell cycle commitment relative to mother cells of the same
size. This asymmetric interpretation of cell size is
associated with differential regulation of the G1 cyclin
CLN3 by Ace2 and Ash1, at least in part via direct binding
of these factors to the CLN3 promoter. CLN3 is the most
upstream regulator of Start, the initiation point of the
yeast cell cycle, and differential regulation of CLN3
accounts for most or all asymmetric regulation of Start in
budding yeast mother and daughter cells.
Asymmetric Cell Cycles in Budding Yeast
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mother cell size control is expected or observed, since mother cells
naturally lack Ace2 and Ash1 due to differential segregation of the
factors at cell division (see Introduction). ace2 ash1 daughters
exhibit efficient size control only when born at a size that mothers
almost always exceed, due to the budding mode of growth
(Figure 1B, 1C) [3].
To test whether Ace2 or Ash1 can affect size control when
introduced into mothers, we used mutations resulting in
symmetrical inheritance of the factors to mothers and daughters.
For Ace2, we used ACE2-G128E (indicated as ACE2* from here
on). Ace2-G128E accumulates symmetrically and activates Ace2-
dependent transcription in both mothers and daughters [20,32]
and was shown previously to reduce mother-daughter G1
asymmetry [28]. For Ash1, we used a mutant (ASH1*) in which
mutation of localization elements in ASH1 mRNA results in
accumulation of Ash1 in both mother and daughter nuclei [33].
As with ace2 ash1 cells, ACE2* ASH1* mothers and daughters
that were born at similar sizes exhibited similar aT1 values
(Figure 2G, 2H; Tables 1, S4). Furthermore, ACE2* ASH1*
mothers, when born sufficiently small, exhibit size control,
essentially as observed in similarly sized wild-type daughters. Such
small mother cells are observed in significant numbers only in
glycerol-ethanol culture (Figure 2H).
Thus, making the Ace2/Ash1 daughter-specific gene expression
program symmetrical between mothers and daughters (either by
deletion or by symmetrical introduction of the factors) results in
effective size control (high negative slope in aT1 versus ln(Mbirth)
plots) over a similar cell size domain in mothers and daughters,
eliminating the daughter-specific delay seen in wild-type. In wild-
type daughters, size control is exerted at sizes where mothers do
not experience size control.
Mother cell size control is in principle hard to detect in any case,
because these cells ‘‘passed’’ size control in the previous cycle, and
budding yeast cell division removes little or no material from the
mother cell. For this reason, even in ACE2* ASH1* cells, which
presumably all have daughter-type size control, mothers small
enough to allow detection of size control are relatively rare.
Strains in which only Ash1 or Ace2 is symmetrically localized
show intermediate phenotypes (Figure 2C–2F; Table 1), suggesting
again that both transcription factors contribute to delay in T1 in
partially independent ways. ACE2* and ASH1* had little effect on
size control properties of daughter cells, as expected since these
factors are already present in wild-type daughters.
Altogether, these results show that Ace2 and Ash1 define
daughter-specific programs that shift size control responses to
larger cell size. Ace2 and Ash1 appear to be necessary for this shift
in size control in daughters compared to mothers; in addition they
are sufficient for imposing daughter-like size control properties
when introduced in mothers.
These results led to the idea that ACE2* ASH1* mothers should
be ‘‘pseudo-daughters’’ with respect to size control, while ace2 ash1
daughters should be ‘‘pseudo-mothers.’’ To test this, we combined
data for mothers and pseudo-mothers, and daughters and pseudo-
daughters, in rich and poor medium (Figure 3A–3F). We define
mothers and pseudo-mothers as ‘‘mother-like,’’ and daughters and
pseudo-daughters as ‘‘daughter-like.’’ Remarkably, these com-
bined data sets collapsed onto one plot for all mother-like cells and
a different plot for all daughter-like cells (Figure 3E, 3F). The
individual datasets fit well with the average behavior, as shown by
plots separating out the various components (Figure S7, S8). The
noise about the lines in these plots (size-independent variation) is of
a magnitude consistent with previous results (Table S5) [5].
Further analysis showed that the daughter-like plot could be
Table 1. Average daughter delay in newborn cells of the same size.
Wild-Type ace2 ash1 ace2 ash1
Daughter-mother delay in glucose 861 min 263 min (0.06) 661 min (0.15) 362 min (0.03)
Daughter-mother delay in gly/eth 8769 min 16613 min (,10
25)4 0 68 min (,10
24)1 7 69 min (,10
27)
Wild-Type ACE2* ASH1* ACE2* ASH1*
Daughter-mother delay in glucose 861 min 1.360.9 min (,10
25)5 61 min (0.03) 1.360.9 min (10
25)
Daughter-mother delay in gly/eth 8769 min 37612 min (,10
23)1 9 67 min (10
28)5 67 min (,10
212)
Wild-Type Ace2/Swi5 Sites Mutated Ash1 sites Mutated Ace2/Swi5 and Ash1 Sites Mutated
Daughter-mother delay in glucose 861 min 862 min (0.82) 1062 min (0.37) 761 min (0.48)
Daughter-mother delay in gly/eth 8769 min 4667 min (,10
23)4 7 615 min (0.02) 5469 min (0.008)
Wild-Type cln3 ADH1pr-CLN3 nxCDC28pr-CLN3
Daughter-mother delay in glucose 861 min 361 min (,10
23) N/A 361 min (,10
23)
Daughter-mother delay in gly/eth 8769 min 9613 min (,10
26)2 2 610 min (,10
25)3 3 612 min (,10
23)
The region of overlap in size at birth of mothers and daughters was evaluated for every genotype separately (see gray bars in Figures 1, 2, 6, and 7). Data for the
duration of T1 in this region were divided in small bins and the daughter delays (i.e., average excess in T1 for daughters over mothers) were computed for every size bin
with representation of both mothers and daughters. The results were averaged across all these size bins. This definition of daughter delay is largely independent of the
uneven distribution of cell size at birth in the region of overlap. The p value, computed by t test, for the hypothesis that the mutant daughter delay is the same as the
wild-type daughter delay is indicated in parentheses. The statistical significance of difference in T1 times between mothers and daughters in the region of size overlap is
presented in Table S4. Asterisks indicate the dominant mutant forms. Data for the difference in T1 in mother-daughter pairs are presented in Figures S4, S5, and S6.
doi:10.1371/journal.pbio.1000221.t001
Figure 1. Differential regulation of Start is dependent on Ace2 and Ash1. (A) Illustration of the separation of G1 into two intervals, T1 and T2,
by using Whi5-GFP. The total duration of G1 is T1+T2. (B–H) Correlation between aT1 and ln(Mbirth) for cells grown in glucose or glycerol/ethanol. (B–C)
wild-type, (D–E) ace2, (F–G) ash1, (H–I) ace2 ash1. Red dots, mothers; blue dots, daughters. Inset: cartoon illustrating presence of Ace2 or Ash1 in
mother and daughter nuclei; black semicircle, Ace2; pink semicircle, Ash1. Gray bars indicate the region of size overlap used for the analysis presented
in Table 1.
doi:10.1371/journal.pbio.1000221.g001
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0.2 units of ln(Mbirth) (Figure 3G, 3H). This implies that, with
respect to Start, cells containing Ace2 and Ash1 interpret a given
cell size as being ,20% smaller than cells lacking Ace2 and Ash1.
These results can be interpreted in the classical framework of
sizers and timers [18,34] by defining the point at which cells switch
from efficient size control to a timer control (the intersection
between the two lines fitting the correlation between aT1 and
ln(Mbirth) in Figure 3C) as ‘‘critical size’’: a precise size that cells
must attain to transit Start. This analogy is imperfect (the slopes
are not 21 or 0, as required for perfect sizers and timers [5,30],
and the sharpness of the transition point cannot be rigorously
determined) but provides a useful simplification using the terms of
prior size control literature. Using this terminology, the effect of
daughter-specific localization of Ace2 and Ash1 is to cause
daughter cells to have a larger ‘‘critical size’’ than mother cells
(increased by 0.2 units of ln(Mbirth), or ,20% larger). We
emphasize that size control remains highly effective, independent
of Ace2 and Ash1; essentially, Ace2/Ash1-containing cells read a
given size as smaller than the same size read in the absence of
Ace2 and Ash1.
Laabs and collaborators reported symmetrical G1 durations
for ace2 mothers and daughters, and for ACE2* mothers and
daughters, independent of cell size [28]. In our experiments, the
loss of asymmetrical ‘‘interpretation’’ of cell size caused by these
mutations does indeed result in T1 durations in mothers and
daughters that are more similar than in wild-type (Figure S4, S5).
However, our results differ in that in our experiments, size control
remains present and effective despite deletion or mislocali-
zation of Ace2 and/or Ash1. As a consequence, the average
daughter T1 is still significantly longer than the average mother T1
(p values,10
23 in glucose; p values,10
214 in glycerol/ethanol)
even in the mutants, since the budding mode of growth ensures
that most daughters are born smaller than most mothers.
This discrepancy likely has a number of sources. First, our use of
T1, the time from cytokinesis to Whi5 nuclear exit as a landmark,
rather than the differential time to budding for mothers versus
daughters, as measured by Laabs and collaborators [28], greatly
increases the sensitivity with which size control can be detected,
since the interval from Whi5 exit to budding is quite variable, cell-
size-independent, and very similar in mothers and daughters [5].
Inclusion of this noisy interval blurs the mother-daughter
distinction, which is restricted to T1. Second, the use of medium
supporting slow cell growth (glycerol-ethanol) enhances the ability
to detect size control, simply because daughters (of all genotypes)
are born much smaller; the work of Laabs et al. [28] employed
only rich glucose medium, making size control harder to detect.
Our time resolution is also 3 min per frame rather than 10.
Finally, our cell size estimates are based on the validated ACT1-
DsRed marker [5], while Laabs et al. [28] employed volume
estimations from geometry of cell images. We have found that the
latter method gives on average similar results to ACT1-DsRed but
increases noise in the detection of size control effects [5].
Genome-Wide Analysis of Ace2 and Ash1 Targets
CLN3 was proposed as the relevant indirect transcriptional
target of Ace2 to account for mother-daughter asymmetry [28].
Because Ace2 could affect other genes involved in cell size control
or mother-daughter asymmetry, and because we had evidence for
the involvement of an independent transcription factor, Ash1, we
carried out an unbiased search for the transcriptional target(s)
through which Ace2 and Ash1 modulate size control in daughters.
We performed microarray analysis of synchronized cell popula-
tions, comparing cells lacking Ace2 and Ash1 to cells in which they
localize symmetrically to both mother and daughter nuclei. Doing
the comparisons in this way, rather than simply comparing wild-
type to mutants, increases sensitivity of the analysis, since wild-type
cultures always contain a mixture of mothers and daughters,
reducing the detectable effects of manipulation of daughter-
specific transcription factors. Our approach relies on three
comparisons: ace2 ash1 versus ACE2* ASH1*, ace2 versus ACE2*,
and ash1 versus ASH1* (see Dataset S2 for the microarrays raw
data).
We also compared swi5, ace2, swi5 ace2, and wild-type in order
to obtain insight into the set of genes regulated by one or both of
these factors (see Dataset S1 for the microarrays raw data). Swi5
and Ace2 are closely related transcription factors that recognize
the same DNA sequence and share many target genes [35,36].
The best characterized Ash1 target, HO, is also a Swi5 target and
its regulation by Swi5 and Ash1 is required for mother-daughter
asymmetry in mating type switching [26,27].
To synchronize cells during the critical M/G1 interval, we used
strains expressing Cdc20 under the control of an inducible
promoter (the truncated GAL1 promoter, GALL [37]). Cells were
arrested in metaphase by depletion of Cdc20 in glucose medium
and released from the arrest by transfer to galactose medium to
reinduce Cdc20. This synchronization procedure provides excel-
lent synchrony in M/G1 (anaphase, cell division, and early G1)
immediately following release, which is the time of nuclear
localization of Ace2, Swi5, and Ash1 (Figure 4A) [36,38].
About 15 min after release, cells of all genotypes complete
anaphase and degrade the mitotic cyclin Clb2 (see Figure 4A).
Subsequently, cells separate and rebud (Figure 4A). Both Swi5 and
Ace2 enter the nucleus at about the time of anaphase (Figure 4A).
On average, Swi5 nuclear entry precedes Ace2 nuclear entry by
2–3 min (see Text S1). A slightly longer (10 min) Ace2 delayrelative
to Swi5 entry was recently reported [39]. Swi5 is rapidly degraded
anddisappearsbeforecytokinesisandcell separation(Figure4Aand
Text S1)[40].Ace2 is quicklyexcluded from themothernucleusbut
remains in the daughter nucleus for a significant period during G1
(Figure 4A and Text S1) [20]. Ash1 protein begins to accumulate a
few minutes after Swi5 and Ace2 nuclear entry and localizes to the
nucleus slightly before cytokinesis, remaining until about the time of
budding (Figure 4A and Text S1) [26].
The microarrays for wild-type cells show well-defined M/G1
and G1/S clusters consistent with previous results (Figure 4B) [38].
Furthermore, well-characterized Ace2 and Ash1 targets, such as
CTS1 and HO, behave as expected upon transcription factor
deletion or mislocalization (see Figure 4C). Cell-cycle-regulated
genes that are unaffected by the two transcription factors behave
very similarly in all arrays (Figure 4C). Note that the time of
anaphase, which varies slightly between experiments, was used as
the zero time to make the comparisons more accurate.
The high reproducibility of these microarray data allows us to
do a time-point by time-point subtraction of the deletion mutant
data from the mislocalization mutant data. This subtraction
Figure 2. Symmetric localization of Ace2 and Ash1 result in symmetric control of Start in mothers and daughters. (A–H) Correlation
between aT1 and ln(Mbirth) for cells grown in glucose or glycerol/ethanol. (A–B) wild-type, (C–D) ACE2*, (E–F) ASH1*, (G–H) ACE2* ASH1*. Red dots,
mothers; blue dots, daughters. Black semicircle, Ace2; pink semicircle, Ash1. Asterisks indicate the dominant mutant forms. Gray bars indicate the
region of size overlap used for the analysis presented in Table 1.
doi:10.1371/journal.pbio.1000221.g002
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independent of Ace2 and/or Ash1, allowing the hierarchical
clustering algorithm [41] to efficiently detect changes that are
specifically due to these transcription factors (see Figure 4C).
Clustering analysis of the subtracted data reveals a clear Ace2-
dependent cluster composed of well-characterized Ace2-depen-
dent genes, such as CTS1, DSE1, and DSE2 (see Text S1 and
Figure S1 for a complete list). Only two genes, HO and PST1,
displayed strong changes in expression upon deletion versus
mislocalization of Ash1 (see Text S1).
None of the genes whose expression was obviously and strongly
Ace2- or Ash1-dependent appeared to be a good candidate to
account for daughter-specific regulation of Start. We therefore
performed a statistical analysis to obtain a list of genes specifically
Figure 3. Daughter-specific localization of Ace2 and Ash1 results in asymmetric cell size control. Correlation between aT1 and ln(Mbirth)
for mothers and ‘‘pseudo-mothers’’ (in (A) cells grown in glucose, in (C) cells grown in glycerol/ethanol) and daughters and ‘‘pseudo-daughters’’ (in
(B) cells grown in glucose, in (D) cells grown in glycerol/ethanol). (E) Correlation between aT1 and ln(Mbirth) for mothers and ‘‘pseudo-mothers’’ grown
in glucose and glycerol/ethanol (pulling together data from (A) and (C)). (B) Correlation between aT1 and ln(Mbirth) for daughters and ‘‘pseudo-
daughters’’ grown in glucose and glycerol/ethanol (pulling together data from (B) and (D)). (G) Correlation between aT1 and ln(Mbirth) in mother-like
and daughter-like cells. The graphs are obtained by binning all the data shown in (E) and (F). Error bars are standard errors of the mean. (H)
Conditional probability of Whi5 nuclear exit as a function of ln(M) from data in (G). f is the probability that Whi5 will exit the nucleus at size ln(M)
given that it had not exited at a smaller size.
doi:10.1371/journal.pbio.1000221.g003
Figure 4. Genome-wide analysis of Ace2 and Ash1 targets. (A) Analysis of cell cycle synchronization and nuclear localization of Ace2, Swi5,
and Ash1 in a cdc20 block-release experiment. Top panel shows the percentage of mononucleate cells, large budded cells, and cells that have
rebudded. The middle panel shows the levels of mitotic cyclin Clb2. The lower panel shows the dynamics of nuclear localization of fluorescently
tagged Ace2, Swi5, and Ash1. (B) Expression data from the M/G1 and G1/S cell cycle regulated cluster of genes. (C) The regulation of CTS1 (Ace2
target), HO (Ash1 target), and SWI5 (Fkh1,2 Mcm1 target) expression from the microarray series, as well as data obtained by point-by-point
subtraction of the arrays (ACE2*2ace2, ASH1*2ash1, ACE2* ASH1*2ace2 ash1). In these graphs, the time of anaphase, which varies slightly between
experiments, was used as the zero time to make the comparisons more accurate.
doi:10.1371/journal.pbio.1000221.g004
Asymmetric Cell Cycles in Budding Yeast
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condition that co-regulated genes should be detected as differential
signals in the subtracted ace2 versus ACE2*, ash1 versus ASH1*,
and ace2 ash1 versus ACE2* ASH1* comparisons. Additionally, we
imposed a temporal requirement that the observed Ace2/Ash1-
dependent changes in expression be observed only at times when
these factors have accumulated in wild-type nuclei (Figure 4A).
This criterion excludes genes whose changes in expression are
long-term, indirect consequences of mutation of Ace2 or Ash1.
Using a p value cutoff sufficient for an expected false positive rate
of less than one gene over the whole genome (see Text S1 and
Table S3), we identified only five Ace2/Ash1 shared targets:
CLN3, HSP150, MET6, YRF1-1, and YRF1-5.
Direct interactions between Ace2 or Ash1 and the promoters of
three of these genes (Ace2 with CLN3 and HSP150; Ash1 with
YRF1-1) were previously observed in chromatin immuno-precip-
itation (ChIP)-chip experiments [42,43], supporting the validity of
our analysis (see Text S1).
Prominent in the list of genes affected by both Ace2 and Ash1 is
the G1 cyclin, CLN3, a rate-limiting activator of the Start
transition. Laabs and collaborators had likewise implicated CLN3
as a gene repressed by Ace2, based on comparing CLN3 RNA
levels with and without Ace2, and examining mother versus
daughter accumulation of GFP driven from a truncated CLN3
promoter [28]. In that paper, it was also suggested that Ace2 might
regulate CLN3 indirectly through an unknown transcription factor
that represses CLN3 expression in daughters by binding to DDE
sites on the CLN3 promoter. Among all the identified Ace2 targets,
Ash1 is the most likely candidate transcription factor for a
repressive role on CLN3 expression. We observe, however, that
there is no obvious homology between the Ash1 consensus and the
DDE. In the next sections we provide evidence that Ash1 binds to
the CLN3 promoter and that this binding is at least in part
mediated by Ash1 consensus-binding sites that are different from
the DDE.
Together, these findings suggested the hypothesis that differen-
tial regulation of Start in mothers and daughters due to Ace2 and
Ash1 may be solely a consequence of differential regulation of
CLN3.
CLN3 expression in M/G1 is from 1.5- to 2.5-fold higher in ace2
ash1 cells (pseudo-mothers) than in ACE2* ASH1* cells (pseudo-
daughters) (Figure 5A), suggesting that CLN3 is differentially
regulated in wild-type mothers and daughters. Previously pub-
lished data support this idea: in populations of cells containing
both mothers and daughters, CLN3 expression peaks at the M/G1
boundary [44], while in populations of size-selected daughters
CLN3 expression peaks later in G1 [45], or shows no peak [12,46],
consistent with our conclusion that CLN3 expression in M/G1 is
higher in mothers than in daughters. M/G1 expression of CLN3 is
driven by Mcm1 through early cell-cycle box (ECB) elements [44];
our results and the results of Laabs and collaborators [28] suggest
that in daughters, Ace2 and Ash1 antagonize this activation.
Hierarchical clustering of microarrays of wild-type and swi5
cells indicates that CLN3 belongs to a cluster of genes whose
expression is activated by Swi5 (Figure 5D). Analysis of ace2 versus
ACE2* arrays (Figure 5B) shows that CLN3 behaves similarly to the
rest of this Swi5 dependent cluster upon manipulation of ACE2
(see Text S1 and Figure S1 for a complete list of Swi5 and Ace2
targets). Expression of these genes in ACE2* cells is lower than
expression in ace2 at 5 min after anaphase, but higher from 15 min
to 25 min (Figure 5E); that is, the genes appear to be repressed by
Ace2 at early times, then activated by Ace2 at later times. This
pattern is significantly different from a pattern assuming no
regulation by Ace2 (p,10
211). CLN3 expression depends on Ace2
similarly to these other Swi5 targets (probability that CLN3 is
regulated as the other Swi5/Ace2 targets: p=0.7, Figure 5E; a
model assuming that CLN3 is not affected by Ace2 can be excluded
with p,0.03, Figure 5F).
Thus CLN3 and a class of Swi5 dependent genes follow a
pattern consistent with early repression and late activation by
Ace2, and with early activation by Swi5, likely acting in concert
with ECB regulation [44]. We do not know the mechanism
underlying this complex pattern. We speculate that Ace2 may be
an intrinsically poorer activator than Swi5, but it activates for a
longer period due to its longer nuclear residence. Swi5 disappears
from both mother and daughter nuclei a few minutes after
anaphase, while Ace2 persists in daughter nuclei for about 20 min
longer (Figure 4A). Competition between Ace2 and Swi5 for the
same binding site [35] could then contribute to the differential
expression observed in these arrays. Alternatively, Ace2 could
directly repress expression of these genes; however, no previous
evidence suggests a directly repressive role for Ace2.
Microarray analysis for ash1 and ASH1* shows that CLN3
expression is repressed about 2-fold by Ash1 during the period
from 10 min to 25 min after anaphase (Figure 5C). During this
interval Ash1 is present in the nucleus (Figure 4A), suggesting that
it could be a direct repressor of CLN3 expression.
Many Swi5 and Ace2/Swi5 targets have moderately higher
expression in the absence of Ash1 (Figure S2). The absolute
repression of Swi5-dependent HO expression by Ash1 in daughter
cells may thus be an enhancement of a common pattern of co-
regulation.
Our data suggest that Ace2 and Ash1 cooperate to repress CLN3
expression in daughters. Consistently, activation of the G1/S
regulon controlled by Cln3 is delayed and/or happens at larger
cell size in cdc20-synchronized cells containing these factors (Figure
S3).
Ace2, Swi5, and Ash1 May Be Direct Transcriptional
Regulators of CLN3
We performed chromatin immuno-precipitation (ChIP) exper-
iments in synchronized cell populations to ask if Ace2, Swi5, and
Ash1 bind to the CLN3 promoter. Genome-wide localization data
in asynchronous cell populations suggested binding of Ace2 and
Swi5 to the CLN3 promoter but were statistically insufficient to
definitively prove the association [42,43]. We used synchronized
cell populations to provide dynamic information on the possible
binding of Ace2, Swi5, and Ash1 to the CLN3 promoter, providing
a higher signal to noise ratio than can be obtained from
asynchronous cells.
Swi5 and Ace2 bound to regions in the CLN3 promoter around
the time of anaphase, coincident with their nuclear entry
(Figure 5G, 5H). Swi5 is on the CLN3 promoter for only a few
minutes (Figure 5G), while Ace2 is on the CLN3 promoter for
about 20 min (Figure 5H), also consistent with the time of Swi5
and Ace2 nuclear localization (Figure 4A and Text S1). Thus,
Ace2 and Swi5 might directly regulate CLN3 transcription by
binding to multiple Ace2/Swi5 sites in the CLN3 promoter.
A previous meta-analysis of multiple ChIP-chip experiments
concluded that Swi5 and Ace2 both bound the CLN3 promoter
with high probability (data in Supp. Table S5 of Ref. [47]),
consistent with our results.
Ash1 binds the CLN3 promoter with kinetics similar to its
nuclear localization (Figure 5I and Figure 4A). In contrast, Ash1
residence at the HO promoter is much briefer, consistent with
previous results [20], despite persistence of Ash1 in the nucleus.
We do not know the reason for this difference.
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PLoS Biology | www.plosbiology.org 9 October 2009 | Volume 7 | Issue 10 | e1000221Figure 5. Ace2, Swi5, and Ash1 regulate the expression of the G1 cyclin CLN3. CLN3 expression: (A) ACE2* ASH1* versus ace2 ash1, (B) ACE2*
versus ace2, (C) ASH1* versus ash1. The error bars were estimated from the variability in expression of the large number of genes that are not affected
by Ace2 and Ash1. The expression levels of CLN3, as well as any other gene in the genome, were estimated by at least four measurements from four
distinct probes. These measurements showed a smaller variability than the presented error bars, suggesting that the reported error bars are a
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CLN3 Promoter Reduce the Asymmetry of Start
Regulation
We noted three candidate Ace2/Swi5 sites (GCTGGS, consensus
sequence: GCTGGT; [42]) in the CLN3 promoter. The CLN3
promoter also contains two possible variant sites (GCTGA); such
sites are over-represented in Ace2 and Swi5 targets (B.F.,
unpublished data). There are eight candidate Ash1-binding sites
(YTGAT)[48]intheCLN3promoter.WemutatedtheseAce2/Swi5
and/or Ash1 putative binding sites in the CLN3 promoter by exact
gene replacement (see Text S1 for details). To test if Ace2, Swi5, and
Ash1 bind to these sites, we performed ChIP analysis in
synchronized populations of heterozygous diploid strains containing
a wild-type copy and a mutated copy of the CLN3 promoter (Ace2/
Swi5 and Ash1 putative binding sites mutated). Following
immunoprecipitation, various regions of the CLN3 promoter were
amplified by PCR and analyzed by sequencing to obtain an estimate
of the ratio of wild-type promoter sequences to mutated sequences
(Figure 6). These experiments are internally controlled (as they do
not require the comparison of two independent ChIP experiments).
The measured ratio provides an indication of the preferential
binding of Ace2, Swi5, and Ash1 to the identified putative binding
sites. Ace2, Swi5, and Ash1 binding to the mutated CLN3 promoter
was reduced to about 60% relative to the wild-type promoter,
assaying multiple sequences from 21,183 to 2998 (ATG: +1)
(Table 2 and Table S6). The binding of Ace2, Swi5, and Ash1 to
sequences from 2767 to 2545 is not altered by mutation of the
putative binding sites (Table 2 and Table S6). These results indicate
that we have identified authentic Ace2, Swi5, and Ash1 binding sites
in the 59 region of the CLN3 promoter. The residual binding signal
from the mutant is consistent with either a low level of background
precipitation, or to genuine residual binding of the factors to non-
consensus sites in the promoter. (Due to uncertainties about such
other sites, as well as variable shearing of the DNA in the ChIP
procedure, we do not think we can use these data to reliably map
which candidate site(s) might be directly bound by Ace2, Swi5, or
Ash1).
conservative estimate of measurement errors. (D) Expression of a cluster of Swi5-dependent genes. Arrays from GALL-CDC20 block release time course
experiments of wild-type and swi5 cells were hierarchically clustered. A Swi5-specific cluster is shown (see Text S1 for a complete list of genes regulated
by Swi5). (E) CLN3 expression compared with the average expression of the remaining genes belonging to the Swi5-specific cluster (error bars indicate
s.e.m.) from the dataset obtained by subtracting the ACE2* data from the ace2 data. (F) CLN3 expression compared with the average expression of the
whole genome (error bars indicate s.e.m.) from the same dataset (i.e. ace22ACE2*). ChIP analysis of the interaction between Swi5 (G), Ace2 (H), Ash1 (I),
and the CLN3 promoter. Following cross-linking andimmunoprecipitation, DNA was amplified by PCR. Amplification of a region of the ORF of DYN1 was
usedas negativecontrols,whileregions oftheSIC1, CTS1,andHOpromoterswereusedaspositivecontrolsforSwi5,Ace2,andAsh1,respectively. All the
strainswere TAP-tagged (NC, negativecontrol from anuntaggedstrain; WCE, wholecell extract).TheChIP data were reproduced forAce2 andAsh1. The
Swi5 data are from a single experiment. (J) Correlation between aT1 and ln(Mbirth) in daughter cells carrying different copy numbers of CLN3.
(K) Representation of the Ace2/Swi5 and Ash1 putative binding sites on the CLN3 promoter.
doi:10.1371/journal.pbio.1000221.g005
Figure 6. Binding of Ace2, Swi5, and Ash1 to the CLN3 promoter is reduced by mutation of the Ace2/Swi5 and Ash1 consensus-
binding sites. Experimental strategy to estimate the preferential binding of Ace2, Swi5, and Ash1 to their consensus-binding sites. Following ChIP,
various regions of the CLN3 promoter were amplified by PCR and analyzed by sequencing to obtain an estimate of the ratio of wild-type promoter
sequences to mutated sequences. This ratio compared to the same ratio from PCR of genomic DNA provides an indication of the preferential binding
of the factors to these sequences (Table 2).
doi:10.1371/journal.pbio.1000221.g006
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in the CLN3 promoter, we carried out a bioinformatics analysis
(Text S1 and Figure S11) looking for regulatory motifs in the
promoters of the identified Ace2 and Swi5 targets in S. cerevisiae
and three closely related yeasts. Interestingly, we found only two
strongly conserved sites: one was one of the candidate Ace2/Swi5
sites we mutated, at position 2701, and the other was a similar but
non-consensus site (GCTTGG) at position 2569, which we did
not mutate since it did not meet the consensus we used in
designing the mutagenesis (see above). It is possible, although still
untested, that this non-consensus site could account for residual
binding of Ace2 to the mutant promoter.
The absence of a cluster of Ash1-dependent genes and the low
information content of the known Ash1 consensus site (YTGAT)
does not allow us to perform similar bionformatics analysis;
therefore, we cannot test the hypothesis that there are non-
consensus Ash1 sites in the CLN3 promoter that we did not
mutagenize.
To test if the reduced binding of Ace2, Swi5, and Ash1 to the
CLN3 promoter also has an effect on the regulation of Start, we
analyzed the correlation between aT1 and ln(Mbirth) in strains
carrying mutations of the identified Ace2/Swi5 and/or Ash1
putative sites. These plots show that these mutations reduce the T1
delay in daughters compared to similarly-sized mothers (Figure 7,
Table 1). The effect is easily detected and statistically significant in
cells grown in glycerol-ethanol (Figure 7), a similar effect was
observed in glucose, but this effect did not reach nominal statistical
significance (Figure S9). In the Ace2/Swi5 sites mutant (Figure 7B,
7D) the duration of T1 in mothers is prolonged, consistent with the
idea that Swi5 is an activator of CLN3 (since mothers do not
contain Ace2). Simultaneous mutation of Ace2 and Ash1 sites did
not significantly enhance the phenotype of mutation only of one or
the other (Figure 7, Table 1).
Although these promoter mutations have significant effects, they
are less potent than deletion of ACE2 and ASH1 (compare Figure 1
with Figure 7, see Table 1). This may be in part due to the
presence of additional non-consensus Ace2/Swi5 or Ash1 sites in
the CLN3 promoter (discussed above). Additionally, the compar-
ison between mutating Ace2 sites and deleting ACE2 is not exact
because removing Ace2 sites perforce also removes Swi5 sites, and
on the other hand, deletion of Ace2 alters ASH1 expression.
The promoter mutants could also be less effective than deletion
of ACE2 and ASH1 because Ace2 has indirect effects on CLN3
expression. It was previously shown that ‘‘DDE’’ sites in the CLN3
promoter play an important role in Ace2-dependent asymmetric
control of Start, but these sites did not appear to be bound by
Ace2, suggesting an indirect mechanism [28]. Interestingly, these
sites are transcribed into the CLN3 mRNA, and the Whi3 RNA
binding protein binds to a repeated RNA sequence at the center of
the DDE [49]. Whi3 is a regulator of cell size control thought to
work by regulation of CLN3 mRNA and protein [49,50,51,52,53].
At present, though, there is no information implicating Whi3 in
mother-daughter asymmetry, nor is Ace2 known to regulate Whi3.
Finally, Ace2/Ash1 could regulate additional G1-regulatory
genes at a level not detectable by our statistical analysis (see above).
The observation that reduced binding of Ace2, Swi5, and Ash1
to the CLN3 promoter results in a significant reduction of
asymmetric control of Start by cell size in mothers and daughters
supports the idea that Ace2 and Ash1 directly repress CLN3
expression in M/G1, accounting for a significant part of the
regulation of G1 length by these transcription factors. We suggest
that direct regulation of CLN3 by Ace2 and Ash1 together with its
indirect regulation by Ace2 through the DDE sites [28] can
explain asymmetric control of Start by cell size in mothers and
daughters.
Changes in CLN3 Expression Are Sufficient to Account for
Mother-Daughter Asymmetry
CLN3 expression in M/G1 is ,2-fold higher in ash1 ace2 cells
(pseudo-mothers) than in ASH1* ACE2* cells (pseudo-daughters)
(Figure 5A). While this change is small, CLN3 is a highly dosage-
sensitive activator of Start. Previous measurements of cell sizes in
cycling cell populations demonstrated effects on cell size upon
2-fold changes up or down in CLN3 gene dosage [10,44].
To increase the precision of this analysis, we analyzed the
correlation between aT1 and ln(Mbirth) in cells carrying either two
or six copies of CLN3. This focuses the analysis on the critical
interval, since Cln3 decreases cell size specifically by decreasing T1
in wild-type mothers and daughters [5].
Daughter cells with two copies of CLN3 exhibit efficient size
control [high negative slope in aT1 versus ln(Mbirth)] over a size
range that is shifted to smaller cell size by ,0.15 units of ln(Mbirth),
compared to wild-type; this shift is similar to that in ace2 ash1
daughter cells (mother-like cells) (compare Figure 5J to Figure 3C).
Thus, the observed ,2-fold changes in CLN3 expression upon
deletion versus mislocalization of Ace2 and Ash1 could account for
the observed changes in cell size control in these mutants.
Six copies of CLN3 almost eliminate size control even in very
small daughter cells (Figure 5J). Thus, size control is remarkably
sensitive to CLN3 gene dosage; it can only be modulated by
altering CLN3 expression in a narrow range before size control is
lost.
Asymmetric Regulation of CLN3 Is Required for
Asymmetric Regulation of Start
We analyzed the correlation between aT1 and ln(Mbirth)i ncln3
cells and in cln3 cells expressing the CLN3 ORF (without the
upstream DDE sites) from constitutive promoters. It is important
for this analysis that the constitutive promoters provide expression
levels of Cln3 similar to those in wild-type cells and that the
promoter-CLN3 fusions complement the large-cell phenotype of
cln3 mutants, without ‘‘overshoot’’ to a small-cell phenotype
Table 2. Ace2, Ash1, and Swi5 Binding to the CLN3 Promoter in Heterozygous Diploids.
Ace2 Ash1 Swi5




Binding ratio (2767: 2545) 1.1560.16 (0.34) 1.0160.16 (0.94) 1.1560.14 (0.29)
The ratio of binding of Ace2, Ash1, and Swi5 to mutated and wild-type CLN3 sequences in heterozygous diploids is reported (in parenthesis is the p value that the
measured ratio is compatible with no change in binding). Binding to the CLN3 promoter region between 21183 and 2998 (ATG: +1) is significantly reduced upon
mutation of the putative Ace2/Swi5 and Ash1 binding sites (see Table S6 for details). Binding to the region from 2767 to 2545 is not affected.
doi:10.1371/journal.pbio.1000221.t002
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promoters of different strengths [55] for these properties,
examining both cell size and Cln3 protein levels using myc-tagged
Cln3, compared to wild-type (including an approximate correction
for cell cycle regulation of CLN3 expression from the endogenous
promoter) (Table 3; [44]).
The ACT1 and the ADH1 promoters result in over-expression of
Cln3 and in a small cell-size phenotype for cells grown in glucose-
containing media (Table 3). Expression of Cln3 from the CDC28
promoter is weaker than expression from the CLN3 promoter and
results in cell sizes bigger than wild-type and only slightly smaller
than cln3 cells (Table 3). Integration into the yeast genome of six
copies of the CDC28pr-CLN3 construct results in a cell size
distribution similar to that of wild-type cells. We also analyzed the
effects of these constructs in glycerol-ethanol medium. Four
tandemly integrated copies of CDC28pr-CLN3 results in an overall
cell size distribution similar to that of wild-type cells in glycerol-
ethanol (Table 3). As a result of decreased ADH1 expression in
non-fermentable media [56], the ADH1 promoter provides Cln3
levels similar to endogenous levels in glycerol-ethanol, resulting in
a cell size distribution slightly (,10%) larger than wild-type
(Table 3).
Measurements of Cln3 protein levels show that Cln3 over-
expressors were smaller than wild-type, and underexpressors larger
(Table 3); therefore, the measurements of Cln3 level were accurate
over a physiologically relevant range. Based on results with a single
copy of CDC28pr-CLN3-myc, four to six copies of CDC28pr-CLN3
should produce approximately wild-type levels of Cln3 in M/G1,
consistent with the observed cell size distributions (Table 3 and
Figure 8).
We therefore used strains containing 6xCDC28pr-CLN3 in
glucose medium, and strains containing 4xCDC28pr-CLN3 or
ADH1pr-CLN3 in glycerol-ethanol medium, to provide approxi-
mately endogenous levels of expression without mother-daughter
asymmetry (and presumably without regulation by the cell cycle,
Ace2, or Ash1; note that the 59 DDE sites are not present in these
Table 3. Levels of Cln3 expression and average cell size for










Cln3 levels in D 1 0 0.4–0.6 5–7 8–10
Cln3 levels in g/e 1 0 0.2–0.5 8–10 1.5–2.0
Cell size in D (fl) 56 92 84 45 45
Cell size in g/e (fl) 47 88 60 41 51
The expression of CLN3 is cell cycle regulated with a peak in expression at M/G1
characterized by a peak to trough ratio of order 3 (see Figure 5) [44]. Since the
period of peak expression is brief, we consider a construct yielding ,3 times
the average expression level of endogenous Cln3 to give approximately wild-
type levels of expression during the critical interval.
doi:10.1371/journal.pbio.1000221.t003
Figure 7. Mutation of the Ace2/Swi5 and Ash1 binding sites on
the CLN3 promoter reduces the asymmetrical regulation of
Start. Correlation between aT1 and ln(Mbirth) for cells grown in
glycerol/ethanol in mutants lacking the Ace2/Swi5 and/or Ash1 sites on
the CLN3 promoter. (A) wild-type, (B) Ace2/Swi5 sites mutated, (C) Ash1
sites mutated, (D) Ace2/Swi5 and Ash1 sites mutated. Red dots,
mothers; blue dots, daughters. Gray bars indicate the region of size
overlap used for the analysis presented in Table 1.
doi:10.1371/journal.pbio.1000221.g007
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almost entirely abolished (Figure 8C, 8E and Table 1). Similarly,
in 4xCDC28pr-CLN3 and ADH1pr-CLN3 cells grown in glycerol/
ethanol, the daughter-specific delay is almost entirely abolished,
and small mothers and daughters have similar size control
properties (Figure 8D, 8F, and 8G and Table 1). Thus, similarly
to the results obtained by placing Ace2 and Ash1 in mother nuclei,
size control in small mother cells can be detected by eliminating
differential mother-daughter control of CLN3 expression.
Small 4xCDC28pr-CLN3 and ADH1pr-CLN3 cells in glycerol/
ethanol exhibit strong size control (slopes of ,20.8, compared to
a theoretical expectation for perfect size control of 21 [5,30])
(Figure 8F, 8G), suggesting that while daughter-specific transcrip-
tional regulation of CLN3 specifies the cell size domain over which
size control is effective, the intrinsic mechanism of size control is
not dependent on mother-daughter regulation of CLN3 transcrip-
tion, or indeed on any transcriptional regulation acting through
the CLN3 promoter. We speculate that an M/G1 burst of CLN3
expression from Mcm1 and/or Swi5 ([44]; Figure 5) may be
sufficient to drive cells rapidly through T1, as is observed in wild-
type mothers of all sizes (Figure 1B, 1C; [5]); in daughters, this
burst may be suppressed by Ace2 and Ash1.
The daughter-specific delay of wild-type cells depends on CLN3,
since cln3 mother and daughter cells of similar size have similar
aT1. Remarkably, cells deleted for cln3 still exhibit strong effects of
cell size on G1 duration, although these effects are symmetrical
between mothers and daughters of similar size (Figure 8C, 8D).
Thus, while the cell size domain of effective size control in wild-
type cells is set by CLN3, there may be an underlying Cln3-
independent or parallel program of cell size control that acts or
becomes detectable only upon deletion of CLN3 [57]. In addition
to loss of mother-daughter asymmetry, the response of cln3 cells to
cell size is shifted to about 1.5-fold larger cell sizes as measured
using ACT1pr-DsRed; this finding confirms that cln3 cells are larger
in terms of protein content than wild-type, in contrast to the
proposal that the increase in cell size of cln3 cells [8,10] is due
primarily or entirely to increased vacuole size [58].
Our results are consistent with those of Laabs and collaborators,
who reported that cln3 cells and cells expressing CLN3 from ectopic
promoters lost mother-daughter asymmetry [28]. They also
observed equal G1 durations for individual mother/daughter
pairs [28]. In our analysis, in contrast, in almost all cln3 mother-
daughter pairs, with or without ectopic expression of CLN3, the
daughters had a longer T1 period (see Figure S6; p values,10
25 in
glucose; p values,10
215 in glycerol/ethanol), although the
daughter delay was reduced compared to wild-type, consistent
with the results of Laabs and collaborators [28]. The symmetry
that we observe in these mutants is restricted to mothers and
daughters of similar size (more precisely, in the mother and
daughter plots of aT1 versus ln(Mbirth), in regions where the
domains of mothers and daughters overlap). We assume this
discrepancy arises from the same reasons discussed above.
Discussion
Cln3, Size Control, and Asymmetric Transcription
It was previously reported that asymmetric localization of Ace2
represses CLN3 in daughter cells [28]. Our results extend this
finding by showing that Ace2 regulation of CLN3 is in part direct,
mediated by Ace2 binding to the CLN3 promoter. In addition, our
results implicate Swi5 and Ash1 as well as Ace2 in CLN3 regulation.
Neither asymmetric expression of CLN3, nor CLN3 itself, is
essential for size control [57] (Figure 8). However, CLN3 sets the
domain of cell sizes over which effective size control operates in
wild-type cells. For this reason, negative control of CLN3 by Ace2
and Ash1 allows differential Start regulation in mothers and
daughters.
These findings provide empirical validation for one part of the
theoretical cycle of transcriptional regulators proposed to account
for a B-type cyclin-independent autonomous transcriptional
oscillator [47].
Do Mothers Drive Start with a Burst of CLN3?
In the budding mode of growth, cell mass produced after
budding goes to the daughter, but all pre-budding mass is retained
by the mother [3]. As a result, a daughter that ‘‘passes’’ size
control will retain this size through all subsequent (mother)
budding cycles. This cell could thus be accelerated through Start
by the M/G1 CLN3 burst without a ‘‘need’’ for size checking.
Given the high amount of noise in the mechanism of size control
[5], this could prevent unnecessary delays in already full-sized
mothers. The M/G1 CLN3 burst, if experienced by daughters,
would perturb the ability of daughters to effectively check their size
(Figure 5J). This could result in the requirement for daughter-
specific blockage to the burst. Thus, mother/daughter-specific
CLN3 regulation could simultaneously prevent unnecessary
mother delays and prevent smaller daughters from passing Start
prematurely.
In addition to repressing initial expression of CLN3 in M/G1,
Ace2 also induces ASH1 expression; Ash1 represses later
expression of CLN3. This is an example of ‘‘feed-forward’’
regulation, which may be a common regulatory structure for
providing delayed response [59]—in this case, prolonged CLN3
repression even after loss of Ace2 from the daughter nucleus. We
speculate that this mechanism may allow daughter-specific delay
over a broad range of timescales and growth rates.
The CLN3 upstream region is unusually large (1.2 kb, compared
to an average intergenic distance of 0.6 kb) and contains six ECB
sites [45], multiple Ace2/Swi5 and Ash1 sites (this work), and four
DDE sites [28]. How all of these sites and the factors that bind to
them cooperate combinatorially to properly regulate CLN3 is
unknown. This is a large amount of regulatory machinery to
provide a maximum peak-to-trough ratio only on the order of
three [44]; however, since manipulation of CLN3 gene copy
number up or down by only a factor of two yields significant cell
size phenotypes (Figure 5J) [10,44], this level of control is likely to
be physiologically significant, perhaps for the reasons cited above.
Sizers, Timers, and Start
As noted above, our results can be interpreted in the classical
framework of sizers and timers [18,34] by defining the point at
which cells switch from efficient size control to a timer control as
‘‘critical size’’ (Figure 3C): a precise size that cells must attain to
transit Start. This point is marked by the intersection of the line of
high negative slope with the line of low or zero negative slope in
Figure 8. Symmetric regulation of CLN3 expression result in symmetric control of Start in mothers and daughters. Correlation
between aT1 and ln(Mbirth) for cells grown in glucose or glycerol/ethanol. (A–B) wild-type, (C–D) cln3, (E) cln3 6xCDC28pr-CLN3, (F) cln3 4xCDC28pr-
CLN3, (G) cln3 ADH1pr-CLN3. Red dots, mothers; blue dots, daughters. Gray bars indicate the region of size overlap used for the analysis presented in
Table 1.
doi:10.1371/journal.pbio.1000221.g008
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summarize our results by stating that Ace2/Ash1-containing cells
have a larger ‘‘critical size’’ than cells lacking these factors
(normally, daughters and mothers, respectively). This formulation
is inexact, primarily due to the evident non-zero slope in our data
for the second component of the two-slope fit; remarkably, though,
the effects of Ace2 and Ash1 shift not just the intersection point but
the entire curve by 0.2 units of ln(Mbirth).
While increasing cell size and increasing Cln3 both decrease T1
(i.e., accelerate Whi5 exit from the nucleus after cytokinesis) [5],
Ace2 exit from the daughter nucleus occurs about 15 min
(1566 min) after cytokinesis, independent of cell size and CLN3
(Text S1 and Figure S10). Thus, overall, Start control may consist
of three distinct modules: Ace2 and Ash1-dependent but cell-size
independent setting of the domain of cell size control; size control
itself, leading to initiation of Whi5 nuclear exit; and a final size-
independent step driven by CLN1,2-dependent transcriptional
positive feedback, which rapidly completes Whi5 exit and drives
the downstream events of Start [5,7].
A New Link between Differentiation and Cell Cycle in
Budding Yeast
In wild-type homothallic budding yeast, only mother cells
express the HO endonuclease and switch mating type, due
to Ash1 repression of HO expression in daughters [26,27].
Phylogenetic analysis shows that in fungi, ASH1 appeared before
HO. This suggests that Ash1 may have functions predating HO,
which may be important for asymmetrical cell division. It would
be interesting to test whether Ash1 functions in cell cycle control
in other fungi that can divide asymmetrically, such as Candida
albicans, which lacks a HO homolog but expresses an Ash1
homolog that localizes specifically to the daughter cells [60,61].
Ash1 also is found in A. gossypii, which undergoes asynchronous
division in a multinucleate syncitium [62]; it would be interesting
to evaluate the role of Ash1 in this asynchrony. Ace2 controls
genes that confer diverse aspects of daughter cell biology
[20,23,24]; here we elucidate how Ace2 also contributes to
differential Start regulation in daughters [28].
There are interesting parallels and connections between HO
control and CLN3 control. Both are activated by Swi5 and
inhibited by Ash1. Swi5 regulation of HO in mothers can be
interpreted as feed-forward control, since Swi5 directly primes HO
for expression [63] and also activates CLN3 expression, which later
yields efficient activation of the SBF factor that drives HO
transcription [7,63].
Cell cycle regulation and cell differentiation, often driven by
asymmetric localization of cell fate determinants during cell
division [64,65,66], are inter-regulated in many systems
[67,68,69]. As the decision of cells to differentiate is often made
in G1, cell differentiation and commitment to a stable G1 are often
coregulated [67,69,70]. It would be interesting to examine cases in
which stem cells produce one proliferating cell and one daughter
that differentiates in G1 [65]; such cells might employ mechanisms
similar to those we have uncovered in differential mother-daughter
G1 control in budding yeast.
Materials and Methods
Strain and Plasmid Construction
Standard methods were used throughout. All strains are W303-
congenic. All integrated constructs were characterized by qPCR.
Mutations of the Ace2/Swi5 and Ash1 binding sites on the CLN3
promoter were verified by sequencing.
Time-Lapse Microscopy
Preparation of cells for microscopy and time-lapse microscopy
were performed as previously described [5,6]. Growth of
microcolonies was observed with fluorescence time-lapse micros-
copy at 30uC using a Leica DMIRE2 inverted microscope with a
Ludl motorized XY stage. Images were acquired every 3 min for
cells grown in glucose and every 6 min for cells grown in glycerol/
ethanol with a Hamamatsu Orca-ER camera. Custom Visual
Basic software integrated with ImagePro Plus was used to
automate image acquisition and microscope control.
Image Analysis
Automated image segmentation and fluorescence quantification
of yeast grown under time-lapse conditions and semi-automated
assignment of microcolony pedigrees were performed as previously
described [6]. The nuclear residence of Whi5-GFP was scored by
visual inspection of composite phase contrast-fluorescent movies.
Cell size was measured as the total cell fluorescence from DsRed
protein, expressed from the constitutively active ACT1pr,a s
previously described [5]. Cell size at every time point was
extrapolated from a linear fit of the ln(M) as a function of time for
cells grown in glucose and from a smoothing spline fit for cells
grown in glycerol/ethanol. Individual cell growth in glycerol/
ethanol appears to be intermediate between a linear and an
exponential model (unpublished data); this deviation from
exponentiality has very little effect on this analysis.
Data Analysis
Time-lapse fluorescence microscopy, microarray data, and
sequencing data were analyzed with custom software written in
MATLAB software (see Text S1 for details on the analysis of the
microarray data) [5]. For cluster analysis, the log2 of the arrays
data or of the subtracted arrays data were hierarchically clustered
by the agglomerative algorithm [41]. Data were visually presented
using JavaTreeView. For sequencing data, the area associated to
every wild-type or mutated nucleotide was evaluated manually by
using the MATLAB software.
Cell Cycle Synchronization
YEP medium was used for all cell cycle synchronization
experiments, supplemented with the appropriate carbon source as
indicated below. Cell cycle synchronization by the cdc20 GALL-CDC20
block release was achieved by growing cells to early log phase in
YEP+galactose (3%), then filtering and growing them in YEP+glucose
(2%) for 3 h to arrest cells in metaphase. Cells were released from the
block by filtering back into YEP+galactose (3%). GALL is a truncated
version of the GAL1 promoter that shows inducible but significantly
l o w e re x p r e s s i o nt h a nt h ef u l l - l e n g t hGAL1 promoter [37].
Microarrays
Microarrays were performed as previously described [71] but
using microarrays carrying PCR fragments from open reading
frames of S. cerevisiae. Each array had each PCR fragment
independently spotted four to eight times, leading to a high
redundancy of data and small errors in expression ratios. RNA
extraction, cDNA synthesis and labeling, and hybridization and
scanning were carried out by the Stony Brook spotted microarray
facility, as described previously [71].
ChIPs
Standard methods were used for ChIP experiments. Early log
phase cells were fixed for 15 min in 1% formaldehyde at room
temperature. Immunoprecipitations were performed with IgG
Sepharose beads. Immunoprecipitated DNA was amplified by PCR.
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Dataset S1 Microarrays data of wild-type, ace2, swi5, and ace2
swi5 synchronized cell populations.
Found at: doi:10.1371/journal.pbio.1000221.s001 (1.48 MB TDS)
Dataset S2 Microarrays data of wild-type, ace2 ash1, ACE2*
ASH1*, ace2, ACE2*, ash1, ASH1* synchronized cell populations.
Found at: doi:10.1371/journal.pbio.1000221.s002 (2.42 MB TDS)
Figure S1 Hierarchical clustering analysis of genes regulated by
Ace2 and Swi5.
Found at: doi:10.1371/journal.pbio.1000221.s003 (9.90 MB TIF)
Figure S2 Ash1 is a modulator of Swi5-dependent expression.
Average expression for Ace2/Swi5 and Swi5 targets (45 genes) in
response to Ash1 (data were obtained by subtracting the ASH1*
dataset from ash1 dataset). This graph shows that Ash1 weakly
represses the expression of many Ace2/Swi5 and Swi5 targets in
daughter cells.
Found at: doi:10.1371/journal.pbio.1000221.s004 (0.87 MB TIF)
Figure S3 Activation of SBF and MBF is delayed by Ace2 and
Ash1. Average expression of 20 SBF/MBF targets in (A) ace2 and
ACE2*, (B) ash1 and ASH1*, (C) ace2 ash1 and ACE2* ASH1* cells.
Distribution of cell size at birth after release from the cdc20 arrest
for (D) ace2 ash1 and (E) ACE2* ASH1* cells.
Found at: doi:10.1371/journal.pbio.1000221.s005 (1.48 MB TIF)
Figure S4 Deletion of ACE2 and ASH1 result in similar T1 only
in mothers and daughter of similar size. Histogram of the
difference in T1 for mother-daughter pairs in wild-type (A, B),
ace2 (C, D), ash1 (E, F), and ace2 ash1 (G, H) cells. T1 is longer in
daughters for almost all mother-daughter pairs, indicating that
symmetrical regulation of Start is restricted to mothers and
daughters of similar size upon deletion of ACE2 and ASH1.
Found at: doi:10.1371/journal.pbio.1000221.s006 (1.98 MB TIF)
Figure S5 Symmetrical distribution of Ace2 and Ash1 result in
similar T1 only in mothers and daughter of similar size. Histogram
of the difference in T1 for mother-daughter pairs in wild-type (A,
B), ACE2* (C, D), ASH1* (E, F), and ACE2* ASH1* (G, H) cells. T1
is longer in daughters for almost all mother-daughter pairs,
indicating that symmetrical regulation of Start is restricted to
mothers and daughters of similar size.
Found at: doi:10.1371/journal.pbio.1000221.s007 (2.07 MB TIF)
Figure S6 Deletion or symmetrical regulation of CLN3 result in
similar T1 only in mothers and daughter of similar size. Histogram
of the difference in T1 for mother-daughter pairs in wild-type (A,
B), cln3 (C, D), 6xCDC28pr-CLN3 (E), 4xCDC28pr-CLN3 (F), and
ADH1pr-CLN3 (G) cells. T1 is longer in daughters for almost all
mother-daughter pairs, indicating that symmetrical regulation of
Start is restricted to mothers and daughters of similar size.
Found at: doi:10.1371/journal.pbio.1000221.s008 (1.98 MB TIF)
Figure S7 Start control is similar in mothers and ‘‘pseudo-
mothers.’’ Plot of aT1 versus ln(Mbirth) for the average ‘‘mother-
like’’ (red dots and error bars, see Figure 3) compared to mothers
and ‘‘pseudo-mothers’’ (black dots).
Found at: doi:10.1371/journal.pbio.1000221.s009 (1.45 MB TIF)
Figure S8 Start control is similar in daughters and ‘‘pseudo-
daughters.’’ Plot of aT1 versus ln(Mbirth) for the average
‘‘daughter-like’’ (blue dots and error bars, see Figure 3) compared
to daughters and ‘‘pseudo-daughters’’ (black dots).
Found at: doi:10.1371/journal.pbio.1000221.s010 (1.53 MB TIF)
Figure S9 Correlation between aT1 and ln(Mbirth) for cells
grown in glucose in mutants lacking the Ace2/Swi5 and/or Ash1
sites on the CLN3 promoter. (A) wild-type, (B) Ace2/Swi5 sites
mutated, (C) Ash1 sites mutated, (D) Ace2/Swi5 and Ash1 sites
mutated. Red dots, mothers; blue dots, daughters.
Found at: doi:10.1371/journal.pbio.1000221.s011 (1.21 MB TIF)
Figure S10 Ace2 nuclear residence is independent of cell size.
Correlation between aTA2, that is, the time of Ace2 nuclear
residence scaled with growth rate a, and ln(Mbirth) for wild-type
daughter cells grown in glucose. Red line: least square fit, slope
<20.2.
Found at: doi:10.1371/journal.pbio.1000221.s012 (0.46 MB TIF)
Figure S11 Phylogenetic analysis of Ace2/Swi5 putative binding
sites on the CLN3 promoter. Ace2/Swi5 consensus-binding site
identified by PhyloGibbs as over-represented motif in the
promoter of the Ace2 and Swi5 targets. Conserved Ace2/Swi5
putative binding sites identified by PhyloGibbs.
Found at: doi:10.1371/journal.pbio.1000221.s013 (0.72 MB TIF)
Table S1 Strains list.
Found at: doi:10.1371/journal.pbio.1000221.s014 (0.10 MB PDF)
Table S2 Plasmids list.
Found at: doi:10.1371/journal.pbio.1000221.s015 (0.06 MB PDF)
Table S3 Analysis of Ace2 and Ash1 shared targets.
Found at: doi:10.1371/journal.pbio.1000221.s016 (0.06 MB PDF)
Table S4 Average daughter delay in new-born cells of the same
size.
Found at: doi:10.1371/journal.pbio.1000221.s017 (0.07 MB PDF)
Table S5 Size-independent noise is similar in daughters and
pseudo-daughters.
Found at: doi:10.1371/journal.pbio.1000221.s018 (0.06 MB PDF)
Table S6 Mutation of Ace2/Swi5 and Ash1 putative sites results
in reduced binding of these factors to the CLN3 promoter.
Found at: doi:10.1371/journal.pbio.1000221.s019 (0.07 MB PDF)
Text S1 Supplementary materials and methods and supplemen-
tary results.
Found at: doi:10.1371/journal.pbio.1000221.s020 (0.13 MB PDF)
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